Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Products & comparisons
Product source

NiaCel 400 (Thorne): DSLD label record for a capsule with two declared ingredients

The DSLD record 323125 lists NiaCel 400 by Thorne as a capsule containing 415 mg nicotinamide riboside hydrogen malate and 85 mg betaine anhydrous per labelled serving. These are label declarations only; the record shows no efficacy, safety, approval or testing. [1]

Automatic summary · not editorially reviewed

Label · NIH DSLD
NiaCel 400Original label · NIH DSLD
NiaCel 400

FROM THE ORIGINAL LABEL

A closer look at the product

Pack contents
60 Capsule(s)
Label serving
1 Capsule(s)
Servings per container
60
Barcode / SKU
6 93749 01208 5
Open original label (PDF)
Ingredients & declared amounts2

Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.

IngredientAmountPer label serving
Nicotinamide Riboside Hydrogen Malate415 mg1 Capsule(s)
Betaine Anhydrous85 mg1 Capsule(s)

Other ingredients: Hypromellose, Calcium Laurate, Microcrystalline Cellulose, Silicon Dioxide

Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.

The key findings

  1. DSLD record 323125 lists NiaCel 400 by Thorne as a capsule in the category "Other Combinations". [1]

  2. The label declares 415 mg nicotinamide riboside hydrogen malate and 85 mg betaine anhydrous per labelled serving. [1]

  3. DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. [1]

The source at a glance

Brand
Thorne
Form
Capsule
Pack contents
60 Capsule(s)
Label serving
1 Capsule(s)
Ingredients listed
Nicotinamide Riboside Hydrogen Malate · Betaine Anhydrous
Record type / format
Dietary supplement label/database record (not a study).
Scope / context
The described product: NiaCel 400 capsules by Thorne, as declared on the label.
Summary based on
Product label / database record

NiaCel 400 capsule record in the NIH DSLD

This is a label record in the NIH Office of Dietary Supplements Dietary Supplement Label Database, record 323125. The declared product name is NiaCel 400, the declared brand is Thorne, and the physical form on the label is capsule. The database category is "Other Combinations". The label entered the database on 2025-01-23; the record notes this is not a product launch date.

Supporting source [1]

Declared ingredients and amounts per labelled serving

The record lists two declared ingredients with amounts where available: nicotinamide riboside hydrogen malate at 415 mg per labelled serving, and betaine anhydrous, labelled as trimethylglycine, at 85 mg per labelled serving. These figures are label facts, not personal dosing advice. The record supplies no independent product testing, price or batch certificate.

Supporting source [1]

What the DSLD listing does not establish

The record states that inclusion in the DSLD does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. It describes label declarations only. Nothing here shows that the product works, is approved or is superior to other products.

Supporting source [1]

How to interpret this

Product label record; not evidence of efficacy or approval. It describes label declarations only, with no independent testing, price or batch certificate.

Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.

Source & supporting passages

[1]
NiaCel 400

Thorne · dsld.od.nih.gov

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    Product label name: NiaCel 400
  2. Finding 2 ↑

    Nicotinamide Riboside Hydrogen Malate: 415 mg
  3. Finding 3 ↑

    DSLD inclusion does not establish efficacy, safety

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…